Product Name:

NebuSelect™ Recombinant Human SETD7, His-tag

Catalog#:

NBL-240534

Description:

NebuSelect™ Recombinant Human SETD7, His-tag(Cat#NBL-240534) is expressed in E.coli with His tag at the N-Terminus.It contains Met1-Lys366.

Species:

Human

Expression System:

E.coli

Molecular Weight: 

The protein has a predicted MW of 41.68 kDa. The protein migrates to 47-50 kDa based on Bis-Tris PAGE result.

Target Name:

SETD7

Target Information:

SETD7 is a methyltransferase that specifically catalyzes the monomethylation of lysine 4 on histone H3. A variety of studies has revealed the role of SETD7 in posttranslational modifications of non-histone proteins. Aberrant expression of SETD7 has been associated with various diseases, including cancer. As a prognostic marker of breast cancer and a novel antioxidant promoter under oxidative stress in breast cancer, SETD7 is considered a good target for the development of new epigenetic drugs.

Amino Acid Sequence: 

Met1-Lys366

Purity:

＞95%

Formulation:

see COA

Endotoxin:

＜1EU/ug(LAL Method)

Storage: 

4°C for short term. 

-20°C for long term.

To get more information, please contact us freely.